ClinicalTrials.Veeva

Menu

The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool

S

Saglik Bilimleri Universitesi

Status

Completed

Conditions

ICU Patients
ICU Acquired Weakness

Treatments

Other: Validation of the Chelsea Critical Care Physical Assesment Tools

Study type

Observational

Funder types

Other

Identifiers

NCT04811638
Saglik Bilimleri University

Details and patient eligibility

About

This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity.

Full description

Survival has increased in the ICU due to technological developments , but physical disability after discharge has become an important problem. İntensive Care Unit Acquired Weakness(ICU-AW) is seen in most of the patients admitted in this unit. The biggest reasons for ICU-AW are; sepsis, multiple organ failure and prolonged mechanical ventilation. The use of measurement tools to evaluate disabilities during stay and after discharge in intensive care unit, is a subject that has been researched all over the world.. These measurement tools provide; monitoring and evaluation during the ICU admission and assessment efficacy of treatment in the unit. The Chelsea Critical Care Physical Assessment Tool(CPAX) has been shown to valid, reliable and to exhibited strong clinimetric properties. CPAx is a numerical measurement tool, rated according to the 6-point Guttman Scale, from complete dependence to independence and consist of ten physical function parameters. This study is aimed at providing an translation and cross-cultural adaptation of Chelsea Critical Care Physical Assesment Tool (CPAx) and tested its reliability and validity. The protocol includes a pre-test of the Turkish version on 10 patients, a final revision, and a validation on a sample of 40 İCU patients.

Enrollment

50 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Older than 18 years
  • Critical adult patients
  • Patients who were hospitalized for more than 48 hours in an ICU

Exclusion criteria

  • Unstable fracture
  • Limb deformities and dysfunction
  • Myasthenia gravis
  • Neuromuscular dysfunction
  • Patients who diagnosed COVİD-19

Trial contacts and locations

1

Loading...

Central trial contact

Esra Pehlivan, Ass.Prof.; Mehmet Burak Uyaroğlu, PT, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems